arrow
I

Inho Kim

korea university medicine (ku medicine)
H指数:27
被引数:3,613

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Serial next-generation sequencing for detecting germline predisposition in acute myeloid leukemia

串联下一代测序用于检测急性髓系白血病中的胚系易感性

2026-02-012
OAAI
Clinical Outcomes of Low-Grade Cytomegalovirus DNAemia in Hematopoietic Stem Cell Transplantation Recipients Receiving Letermovir Prophylaxis

低度巨细胞病毒DNA血症在造血干细胞移植接受者中接受莱特莫韦预防的临床结局

2025-12-040
PRE
Risk stratification of low-dose cytarabine and venetoclax in patients with AML ineligible for intensive chemotherapy

低剂量阿糖胞苷和维奈克拉在不符合强化疗条件的急性髓系白血病患者中的风险分层

2025-11-240
OAAI
Venetoclax or placebo in combination with bortezomib and dexamethasone in relapsed or refractory multiple myeloma (BELLINI): final overall survival results from a randomised, phase 3 study

维奈克拉或安慰剂联合硼替佐米和地塞米松治疗复发或难治性多发性骨髓瘤(BELLINI):一项随机、III期研究的最终总生存结果

2025-06-270
PRE
Serial Next-Generation Sequencing for Detection of Germline Predisposition in Acute Myeloid Leukemia

串联下一代测序在急性髓系白血病中胚系易感性的检测应用

BLOOD
IF23.1
2024-11-050
PRE
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3trial
2024-10-013
PRE
Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease
2024-09-196
PRE
Effect of BCR::ABL1 transcript type and droplet digital polymerase chain reaction on successful treatment-free remission in chronic myeloid leukemia patients who discontinued tyrosine kinase inhibitor

BCR::ABL1转录本类型和液滴数字聚合酶链反应对停用酪氨酸激酶抑制剂的慢性粒细胞白血病患者成功无治疗缓解的影响

2023-11-022
OAAI
A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
2023-01-130
PRE